Pharma Tariffs: US Government backtracks

Biologics CDMO Rezon Bio leaves stealth mode

Genmab swallows Merus in US$8bn deal

MSD Secures Option on EVX-B3

Trump Targets Overseas with 100%-Tariff

UniQure’s stocks up after AMT-130 trial win

Siemens Healthineers enters CRISPR diagnostics space

Revyve scaling up production by €24m financing

Roche moves obesity asset CT-388 into Phase III

Genfit SA discontinues lead programme